Solifenacin for overactive bladder: a systematic review and meta-analysis

Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms

(2010) Scott R. Serels et al.   CURRENT MEDICAL RESEARCH AND OPINION

Solifenacin for overactive bladder: secondary analysis of data from VENUS based on baseline continence status

(2010) Marc R. Toglia et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Solifenacin and Tolterodine are Equally Effective in the Treatment of Overactive Bladder Symptoms

(2010) Chen-Hsun Ho et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial

(2009) M. D. Vardy et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Solifenacin for Overactive Bladder: Patient-Reported Outcomes from a Large Placebo-Controlled Trial

(2009) Marc R. Toglia et al.   POSTGRADUATE MEDICINE

Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial

(2008) Linda Cardozo et al.   BJU INTERNATIONAL

The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis

(2008) Christopher R. Chapple et al.   EUROPEAN UROLOGY

Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study

(2008) M.-S Choo et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Treatment With Solifenacin Increases Warning Time and Improves Symptoms of Overactive Bladder: Results From VENUS, a Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Mickey M. Karram et al.   UROLOGY